Attached files

file filename
EX-99.1 - EX-99.1 - NEOPHOTONICS CORPnptn-20170803ex991718682.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  August 3, 2017

 

NEOPHOTONICS CORPORATION

(Exact name of registrant as specified in its charter)

 

DELAWARE

 

001-35061

 

94-3253730

(State of incorporation)

 

(Commission File No.)

 

(IRS Employer Identification No.)

 

NeoPhotonics Corporation

2911 Zanker Road

San Jose, California 95134

(Address of principal executive offices and zip code)

Registrant’s telephone number, including area code: (408) 232-9200

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 


 

ITEM 2.02          RESULTS OF OPERATIONS AND FINANCIAL CONDITION

On August 3, 2017, the Company issued a press release regarding the Company’s financial results for the second quarter ended June 30, 2017.  A copy of the Company’s press release is furnished and attached as Exhibit 99.1 to this Form 8-K.

The information contained in this Item 2.02, including Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and shall not be incorporated by reference in any registration statement or other document filed under the Securities Act or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filings, except as shall be expressly set forth by specific reference in such a filing.

 

 

ITEM 9.01          FINANCIAL STATEMENTS AND EXHIBITS.

 

(d)Exhibits.

 

 

 

 

Exhibit Number

    

Description

 

 

 

99.1

 

Press Release issued by NeoPhotonics Corporation on August 3, 2017, regarding the Company’s financial results for the second quarter ended June  30, 2017.

 

2


 

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 

Arch

 

 

 

 

Date: August 3, 2017

    

NEOPHOTONICS CORPORATION

 

 

 

 

 

 

 

 

By:

/s/ Sandra A. Waechter

 

 

 

 

Sandra A. Waechter

 

 

 

 

Interim Chief Financial Officer

 

 

 

 

3


 

INDEX TO EXHIBITS

   

Pril

 

 

Exhibit Number

    

Description

 

 

 

99.1

  

Press Release issued by NeoPhotonics Corporation on August 3, 2017, regarding the Company’s financial results for the second quarter ended June  30, 2017.

 

   

   

 

 

4